Displaying drugs 251 - 275 of 407 in total
| Name | Weight | Structure | Desription | Categories |
|---|---|---|---|---|
| Factor IX Complex (Human) | Not Available |  | A Factor IX complex used to prevent and treat bleeding episodes in hemophilia B or vitamin K antagonist therapy. | Blood Coagulation Factors / Enzyme Precursors / Factor IX |
| Exenatide | 4186.6 C184H282N50O60S |  | A GLP-1 agonist used in the management of type 2 diabetes mellitus. | Glucagon-like peptide-1 (GLP-1) analogues |
| Evolocumab | 141800.0 C6242H9648N1668O1996S56 |  | A PCSK9 (proprotein convertase subtilisin kexin type 9) inhibitor antibody used as an adjunct to LDL cholesterol reducing therapies, aiding in the prevention of cardiovascular events and cardiovascular revascularization procedures. | Anticholesteremic Agents / Hypolipidemic Agents Indicated for Hyperlipidemia / PCSK9 Inhibitor |
| Evinacumab | 146000.0 | | A monoclonal antibody targeted against angiopoetin-like protein 3 (ANGPTL3) used as an adjunct with other lipid-lowering therapies for the treatment of homozygous familiar hypercholesterolemia. | Angiopoietin-like 3 Inhibitor |
| Etanercept | 51234.9 C2224H3475N621O698S36 |  | A protein therapy based on the binding fragment of the tumour necrosis factor alpha receptor used to treat severe rheumatoid arthritis and moderate to severe plaque psoriasis. | Tumor necrosis factor alpha (TNF-alpha) inhibitors |
| Erythropoietin | 18396.1 C815H1317N233O241S5 |  | A recombinant form of human erythropoietin used to increase differentiation of progenitor cells to red blood cells in the treatment of anemia. | Colony-Stimulating Factors / Erythropoiesis-Stimulating Agents / Erythropoietin, genetics / Hematinics |
| Erenumab | C6472H9964N1728O2018S50 | | A calcitonin-gene related peptide antagonist used to prevent migraines. | Calcitonin Gene-Related Peptide (CGRP) Antagonists / Calcitonin Gene-Related Peptide Receptor Antagonists |
| Equine Botulinum Neurotoxin G Immune FAB2 | Not Available | | A mixture of antibodies used to treat documented or suspected botulinum toxin exposure. | Not Available |
| Equine Botulinum Neurotoxin F Immune FAB2 | Not Available | | A mixture of antibodies used to treat documented or suspected botulinum toxin exposure. | Not Available |
| Equine Botulinum Neurotoxin E Immune FAB2 | Not Available | | A mixture of antibodies used to treat documented or suspected botulinum toxin exposure. | Not Available |
| Equine Botulinum Neurotoxin D Immune FAB2 | Not Available | | A mixture of antibodies used to treat documented or suspected botulinum toxin exposure. | Not Available |
| Equine Botulinum Neurotoxin C Immune FAB2 | Not Available | | A mixture of antibodies used to treat documented or suspected botulinum toxin exposure. | Not Available |
| Equine Botulinum Neurotoxin B Immune FAB2 | Not Available | | A mixture of antibodies used to treat documented or suspected botulinum toxin exposure. | Not Available |
| Equine Botulinum Neurotoxin A Immune FAB2 | Not Available | | A mixture of antibodies used to treat documented or suspected botulinum toxin exposure. | Not Available |
| Eptotermin alfa | Not Annotated | | A bone morphogenetic protein that is widely expressed during EMBRYONIC DEVELOPMENT. It is both a potent osteogenic factor and a specific regulator of nephrogenesis. Eptotermin alfa is an ingredient in... | Bone Morphogenetic Proteins |
| Eptinezumab | 143000.0 | | A monoclonal antibody directed against CGRP infused every 3 months for the preventive treatment of migraine in adults. | Calcitonin Gene-related Peptide Antagonist |
| Eptifibatide | 831.962 C35H49N11O9S2 | | A peptide-based antagonist for glycoprotein IIb/IIIa used in the medical management of myocardial infarction and as an adjunct to percutaneous coronary intervention. | Platelet Aggregation Inhibitors Excl. Heparin |
| Epoetin delta | Not Annotated | | Epoetin Delta is an ingredient in the EMA-withdrawn product Dynepo. | Amino Acids, Peptides, and Proteins / Biological Factors / Carbohydrates / Colony-Stimulating Factors / Cytokines / Glycoconjugates / Glycoproteins / Hematopoietic Cell Growth Factors / Intercellular Signaling Peptides and Proteins / Peptides / Proteins |
| Epcoritamab | 149000.0 C6471H9999N1735O2007S44 | | A bispecific CD20-directed CD3 T-cell engager used to treat relapsed or refractory diffuse large B-cell lymphoma (DLBCL) in adults. | Amino Acids, Peptides, and Proteins / Antibodies, Monoclonal / Antibodies, Monoclonal, Humanized / Antineoplastic Agents / Bispecific Monoclonal Antibodies / Blood Proteins / Cancer immunotherapy / CD20-directed Antibody Interactions / CD3-directed Antibody Interactions / Immunoglobulins / Immunotherapy / Increased Cytokine Production / Proteins / Serum Globulins |
| Enfuvirtide | 4491.876 C204H301N51O64 |  | An HIV-1 gp41 fusion inhibitor used in patients experiencing HIV-1 replication who are already being treated with other anti-retrovirals. | HIV Envelope Protein gp41 / HIV Fusion Inhibitors / Human Immunodeficiency Virus 1 Fusion Inhibitor / Peptide Fragments |
| Enfortumab vedotin | 152000.0 | | An antibody-drug conjugate comprised of a fully human monoclonal antibody and microtubule-disrupting chemotherapeutic agent used in the treatment of advanced or metastatic urothelial cancer. | Amino Acids, Peptides, and Proteins / Antibodies / Antibodies, Monoclonal / Antibodies, Monoclonal, Humanized / Antibody-drug Conjugates / Antineoplastic Agents / Antineoplastic and Immunomodulating Agents / Blood Proteins / Cancer immunotherapy / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Substrates / Globulins / Immunoglobulins / Immunoproteins / Immunotherapy / Microtubule Inhibitors / MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES / Nectin-4-directed Antibodies / P-glycoprotein substrates / Proteins / Serum Globulins |
| Emicizumab | 145637.0 C6434-H9940-N1724-O2047-S45 |  | An antibody against Factor IXa and Factor X used to treat hemophilia A. | Amino Acids, Peptides, and Proteins / Antibodies / Antibodies, Monoclonal / Antibodies, Monoclonal, Humanized / Antihemorrhagic Agents, Miscellaneous / Blood and Blood Forming Organs / Blood Coagulation Factors / Blood Proteins / Globulins / Hemostatics / Immunoglobulins / Immunoproteins / Proteins / Serum Globulins |
| Emapalumab | 154400.0 C6430H9898N1718O2038S46 | | An interferon gamma blocking antibody used to treat primary hemophagocytic lymphohistiocytosis. | Selective Immunosuppressants |
| Elranatamab | 148500.0 C6440H9958N1738O2010S49 | | A bispecific antibody used to treat adults with relapsed or refractory multiple myeloma. | Amino Acids, Peptides, and Proteins / Antibodies, Monoclonal / Bispecific B-cell maturation antigen (BCMA)-directed CD3 T-cell engager / Bispecific Monoclonal Antibodies / Blood Proteins / Immunoglobulins / Proteins / Serum Globulins |
| Elotuzumab | 148100.0 C6476H9982N1714O2016S42 |  | An antineoplastic agent and SLAMF7-directed immunostimulatory antibody used for the treatment of refractory multiple myeloma in combination with other antineoplastic agents. | Antibodies, Monoclonal |
Displaying drugs 251 - 275 of 407 in total